Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05666128

Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Conditions: Type 2 Diabetes Mellitus

Sex: All

Ages: 19 Years – 75 Years

Healthy volunteers: 1

Phase: PHASE2

Enrollment: 113

Sponsor: Hyundai Pharm

Location: Korea, Republic of

Summary

A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Eligibility Criteria

Inclusion Criteria:Diagnosis of T2DM with HbA1c between 7.0% and 10.0% (inclusive) while on diet and exercise alone for at least 6 weeks prior to screening.Exclusion Criteria:Type 1 diabetes or another immune-mediated diabetes syndrome

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05666128). StuddyBuddy aggregates publicly available trial information.